Literature DB >> 29788200

Mycoplasma pneumoniae as a Cause of Community-Acquired Pneumonia in Children.

Samir S Shah1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 29788200     DOI： 10.1093/cid/ciy421

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  4 in total

1.  Comparative efficacy and safety of traditional Chinese patent medicine in the treatment of Mycoplasma pneumoniae pneumonia in children: A protocol for systematic review and meta-analysis.

Authors:  Hongan He; Xiao Wang; Yanyan Xiao; Jialin Zheng; Jinjuan Wang; Baoqing Zhang
Journal:  Medicine (Baltimore)       Date:  2020-12-18       Impact factor: 1.817

2.  Efficacy of Gamma Globulin Combined with Azithromycin Sequential Therapy in the Treatment of RMPP and Its Effect on Th1/Th2 Cytokine Levels.

Authors:  Jie Qi; Fang Jia; Hui Tian; Shengmei Yang
Journal:  Comput Math Methods Med       Date:  2022-07-20       Impact factor: 2.809

3.  Novel Functional eQTL-SNPs Associated With Susceptibility to Mycoplasma pneumoniae Pneumonia in Children.

Authors:  Yang Dong; Yanmin Gao; Cheng Luo; Nengshun Wu; Zhounan Cheng; Anni Qiu; Yan Zhou; Wendi Zhang; Minjie Chu; Qing Chang
Journal:  Front Public Health       Date:  2022-06-28

4.  Paediatric critical illness associated with respiratory infection: a single-centre, retrospective cohort study.

Authors:  Haifa Alfaraidi; Kathy Luinstra; Alireza Eshaghi; Marek Smieja; Jonathan B Gubbay; Jeffrey M Pernica
Journal:  BMJ Paediatr Open       Date:  2020-04-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.